Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lapointe

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Clinical and Diagnostic Virology|May 1, 1997
Evaluation of a non-isotopic polymerase chain reaction assay for detection in clinical specimens of herpes simplex virus type 2 DNA. Canadian Women's HIV Study GroupC Tremblay, F Coutlée, J Weiss, et al.
Journal of Clinical Microbiology|May 15, 1999
Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study groupF Coutlée, P Gravitt, H Richardson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 10, 1999
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study GroupC Hankins, F Coutlée, N Lapointe, et al.
The Journal of Infectious Diseases|April 16, 1998
Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothersL Pedneault, N Lapointe, C Alfieri, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitroJ Bouchard, M C Walker, J M Leclerc, et al.
The American Journal of Medicine|January 1, 1987
Detection of human immunosuppressive virus in salivary lymphocytes from dental patients with AIDSD Pekovic, D Ajdukovic, C Tsoukas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1996
Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virusL Pedneault, N Lapointe, C Alfieri, et al.
AIDS (London, England)|June 15, 2000
Human herpesvirus 8 infection of the genital tract of HIV-seropositive and HIV-seronegative women at risk of sexually transmitted diseases. Canadian Women's HIV Study GroupG Boivin, C Hankins, N Lapointe, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 1, 1994
Canadian national survey of perinatal HIV infection 1991-1992. Canadian Paediatric AIDS Research Group (CPAR)F P Duff, S M King, N Lapointe, et al.
L'Union Medicale Du Canada|July 1, 1985
[Clinical observations on 76 children exposed to urea-formaldehyde insulation foam]J Lacroix, Z Chad, M Gauthier, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Clinical and Diagnostic Virology|May 1, 1997
Evaluation of a non-isotopic polymerase chain reaction assay for detection in clinical specimens of herpes simplex virus type 2 DNA. Canadian Women's HIV Study GroupC Tremblay, F Coutlée, J Weiss, et al.
Journal of Clinical Microbiology|May 15, 1999
Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study groupF Coutlée, P Gravitt, H Richardson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 10, 1999
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study GroupC Hankins, F Coutlée, N Lapointe, et al.
The Journal of Infectious Diseases|April 16, 1998
Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothersL Pedneault, N Lapointe, C Alfieri, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitroJ Bouchard, M C Walker, J M Leclerc, et al.
The American Journal of Medicine|January 1, 1987
Detection of human immunosuppressive virus in salivary lymphocytes from dental patients with AIDSD Pekovic, D Ajdukovic, C Tsoukas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1996
Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virusL Pedneault, N Lapointe, C Alfieri, et al.
AIDS (London, England)|June 15, 2000
Human herpesvirus 8 infection of the genital tract of HIV-seropositive and HIV-seronegative women at risk of sexually transmitted diseases. Canadian Women's HIV Study GroupG Boivin, C Hankins, N Lapointe, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 1, 1994
Canadian national survey of perinatal HIV infection 1991-1992. Canadian Paediatric AIDS Research Group (CPAR)F P Duff, S M King, N Lapointe, et al.
L'Union Medicale Du Canada|July 1, 1985
[Clinical observations on 76 children exposed to urea-formaldehyde insulation foam]J Lacroix, Z Chad, M Gauthier, et al.
Pageof 9